ENEuripedes Gomes de Carvalho Neto

Euripedes Gomes de Carvalho Neto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Euripedes Gomes de Carvalho Neto has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Teaching NeuroImage: Mees Lines as a Clinical Clue to Arsenic Poisoning

    by Euripedes Gomes De Carvalho Neto, Mateus Damiani Monteiro, Carlos Roberto de Mello Rieder

  • Open Access

    The whistle-smile reflex in Parkinson's disease: an exploratory case-control study

    by Mateus Damiani Monteiro, Eurípedes Gomes de Carvalho Neto, Liana Lisboa Fernandez, Arlete Hilbig, Carlos Roberto de Mello Rieder

    Parkinson's disease (PD) is a well-known neurodegenerative disease characterized by tremors, rigidity, and bradykinesia. In 1943, Frederic Hanes described the whistle-smile reflex (WSR), noting its absence in PD patients due to reduced facial movements. To assess the WSR's diagnostic performance. In the current cross-sectional study, we selected PD patients and healthy controls. They were filmed while asked to whistle, and a blinded physician assessed if the individuals smiled or not. Absence of smiling after whistling was considered a positive test. We stratified the smiling intensity into 4 groups. We calculated the odds ratio (OR) of the positive WSR in PD and asymptomatic patients, which was reported with CIs, sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and we plotted a receiver operating characteristic (ROC) curve. We identified 43 patients with PD (mean age = 63 ± 10 years; 30% of female subjects) and 44 asymptomatic controls (mean age = 64 ± 10 years; 51% of female subjects). The WSR test was positive in 35/43 PD cases versus 7/44 in the asymptomatic group (OR = 23.1; 95%CI = 7.6–70.5; SE = 81.4%; SP = 84.1%; PPV = 83.3%; NPV = 82.2%). When stratified considering the group with the least intense smile as a positive test, the test was positive in 42/43 PD cases versus 23/44 in the asymptomatic group (OR = 38.3; 95%CI = 4.8–303.7; SE = 97.7%; SP = 47.7%; PPV = 64.6%; NPV = 95.4%). The WSR test showed a good performance in identifying PD patients; it may complement the physical examination, and its result may be a useful finding during the assessment of a patient with PD.

  • Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature review

    by Juan Sebastián Sánchez León, Eurípedes Gomes de Carvalho Neto, Natana Rangel Ribeiro, Vanessa Dantas de Andrade, Augusto Berton Bettiol, Rafael Coradin, Marlise Ribeiro de Castro

    1. Autoimmune encephalitis (AE) is an inflammatory disease of the brain with diverse etiologies, making diagnosis challenging due to its wide range of clinical manifestations [1]. It typically pres...

  • Open Access

    Prevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients

    by Eurípedes Gomes de Carvalho Neto, Nayron Medeiros Soares, Gabriela Magalhães Pereira, Bárbara Maldotti Dalla Corte, Ana Carolina Leonardi Dutra, Nathalie Ribeiro Artigas, Rosa Maria Martins de Almeida, Júlia Schneider Krimberg, Bruno Elkfury Monticelli, Artur Francisco Schumacher Schuh, et al.

    Impulse control disorders (ICDs) are potentially serious complications of Parkinson's disease (PD). Treatment, particularly the use of dopamine agonists (DAs), is associated with the development of ICDs and related behaviors. However, susceptibility to these disorders appears to be linked to specific risk factors. To assess the frequency, clinical presentation, and factors associated with the development of ICDs in a population of patients with PD. Patients with PD were screened for ICD-related symptoms using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson''s Disease -Current Short (QUIP-CS) questionnaire. Additionally, they underwent cognitive evaluation and were assessed using the Movement Disorder Society–Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Sociodemographic data and disease progression information were collected. Levodopa equivalent daily dose (LEDD) was calculated for each patient. Of the 90 patients evaluated, 42 (46.6%) exhibited symptoms of ICDs. The most frequent subtype was binge eating (50%), followed by compulsive buying (33.3%) and hypersexuality (21.4%). A significant association was found between DA use and the development of ICDs (p = 0.041). Patients with ICDs using DAs had a higher mean LEDD (p < 0.001) and a higher frequency of motor complications (MDS-UPDRS Part IV, p = 0.028) compared to those not using DAs. In the current study, the use of DAs was the main risk factor associated with the development of impulse control disorders. No other significant associated factors could be identified.


  • Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis

    by Euripedes Gomes de Carvalho Neto, Matheus Ferreira Gomes, Iuri Pereira dos Santos, Mateus Damiani Monteiro, Ana Maria Hoppe, Francisco Tellechea Rotta

  • Open Access

    Characterization of the nigroestriatal system in a sample of patients with amyotrophic lateral sclerosis

    by Claudio Alejandro Jimenez Monsalve, Luis Henrique Tieppo Fornari, Neivo da Silva Júnior, Douglas Tomio Nakata, Eurípedes Gomes de Carvalho Neto, Francisco Tellechea Rotta, Carlos Roberto de Mello Rieder

    Background The coexistence of amyotrophic lateral sclerosis (ALS) with clinical forms of Parkinson disease (PD), although uncommon, is found to a greater degree than one would expect by chance. The pathological mechanisms of ALS and PD are still not fully understood, and the coexistence of these two diseases suggests that they could share mechanisms in common. Objective Here we present a sample of patients with clinically definitive or probable ALS who were evaluated with single-photon emission computed tomography SPECT/TRODAT and compared with non-ALS controls. Methods Patients with clinically definite or probable ALS were assessed with the amyotrophic lateral sclerosis functional rating scale (ALSFRS) to define severity and had their demographic data collected. The TRODAT results of patients with ALS were compared with those of patients with a diagnosis of PD with less than 10 years of duration, and with patients with a diagnosis of others movement disorders not associated with neurodegenerative diseases. Results A total of 75% of patients with ALS had TRODAT results below the levels considered normal; that was also true for 25% of the patients in the control group without neurodegenerative disease, and for 100% of the patients in the PD group. A statistically significant difference was found between patients with ALS and the control group without neurodegenerative disease in the TRODAT values < 0.05. Conclusions Our study fits with the neuropathological and functional evidence that demonstrates the existence of nigrostriatal dysfunction in patients with ALS. Further research to better understand the role of these changes in the pathophysiological process of ALS needs to be performed.


  • Open Access

    The whistle-smile reflex: a missed sign

    by Mateus Damiani Monteiro, Giovanna Testa Brustolin, Eurípedes Gomes de Carvalho Neto, Carlos Roberto de Melo Rieder

    In this paper, we present a historical review of the whistle-smile reflex, a semiological sign missed in the literature and clinical practice.


  • Open Access

    Anti-Ri autoimmune encephalitis associated with breast cancer

    by Euripedes Gomes de Carvalho Neto, Matheus Ferreira Gomes, Ronnie Peterson Marcondes Alves, Alexei Peter dos Santos, Cristiano Brum, Ricardo Santin


  • The medial hamstring (L5) reflex

    by Euripedes Gomes de Carvalho Neto, Matheus Ferreira Gomes, Mateus Damiani Monteiro, Barbara Maldotti Dalla Corte, Ana Maria Hoppe, Francisco Tellechea Rotta


  • Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis

    by Euripedes Gomes de Carvalho Neto, Matheus Ferreira Gomes, Iuri Pereira dos Santos, Mateus Damiani Monteiro, Ana Maria Hoppe, Francisco Tellechea Rotta